EEF2K and breast carcinoma: Among a series of synthesized analogues with linkers of various chain length and constitution, compound 11 (“11l”, Figure 5) had the maximum eEF2K degradation rate (Dr) value of 56.7% and could induce apoptosis in human breast carcinoma MDA-MB-231 cells in vitro [87].